Ticker Details
Genelux Corporation Common Stock
IPO Date:	January 26, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$118.06M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 4.76%
Avg Daily Range (30 D):	$0.07 | 2.46%
Avg Daily Range (90 D):	$0.18 | 3.68%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.24M

Trade Size
Avg Trade Size (Sh.):	106
Avg Trade Size (Sh.) (30 D):	116
Avg Trade Size (Sh.) (90 D):	113

Institutional Trades
Total Institutional Trades:	30
Avg Institutional Trade:	$3.3M
Avg Institutional Trade (30 D):	$.71M
Avg Institutional Trade (90 D):	$.75M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.12M
Avg Closing Trade (30 D):	$.71M
Avg Closing Trade (90 D):	$.71M
Avg Closing Volume:	400.2K

News

Jan 12, 2026 @ 9:00 PM Genelux Corporation Announces Upcoming Virtual Fir... Source: Not Specified

Jan 2, 2026 @ 1:00 PM Genelux Corporation Announces Appointment of Jason... Source: Na

Sep 3, 2024 @ 8:01 PM Genelux Corporation to Present at the H.C. Wainwri... Source: N/A

Jul 30, 2024 @ 11:00 AM Genelux Corporation to Participate in Fireside Cha... Source: N/A

May 31, 2024 @ 4:01 PM Unveiling 4 Analyst Insights On Genelux Source: Benzinga Insights

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.88	$-.21	$-.2
Diluted EPS	$-.88	$-.21	$-.2
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-31.87M	$-7.95M	$-7.46M
Operating Income / Loss	$-33.55M	$-8.19M	$-7.79M
Cost of Revenue
Net Cash Flow	$-1.41M	$-1.85M	$-9.66M
PE Ratio